Furthermore, multivariate analyses with adjustments for age, sex, and total resection status, all of which are relevant clinical covariates, indicated that high levels of ATF4, GLUT5, and ALDOB expression were independent prognostic factors for overall survival of GBM patients (Supplementary Table 2). This evidence concerns the gene SLC2A5 and glioblastoma.